ArticleVirus genes2026
Molecular epidemiology of human rhinovirus in coastal China: genotyping and epidemic trends in Daishan (2022-2023).
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
To investigate the positive rate and molecular epidemiological characteristics of human rhinovirus (HRV) in influenza-like illness (ILI) cases in Daishan, Zhejiang Province. Throat swab specimens from ILI cases were collected from a hospital in Daishan, Zhejiang Province, between January 2022 and December 2023. Real-time PCR was performed to identify 14 common respiratory pathogens. Nested PCR was performed to amplify the VP4/VP2 gene sequences of HRV-positive specimens. Phylogenetic analyses were conducted based on the VP4/VP2 regions of HRV. A total of 1,255 specimens were collected. The overall positive rate for respiratory pathogens was 54.34% (682/1,255), with HRV detected in 7.57% (95/1,255) of the cases. Three genotypes of HRV were identified, encompassing 25 serotypes, including 15 types of HRV-A, 5 types of HRV-B, and 5 types of HRV-C. HRV was one of the main pathogens causing respiratory tract infections in Daishan, Zhejiang Province, from January 2022 to December 2023. The prevalence of HRV was complex, with HRV-A being the predominant genotype, while HRV-A, HRV-B, and HRV-C were co-prevalent. Continuous monitoring of HRV infections is recommended.
Indexed as
Identifiers
42502147What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.